ASN: Discontinuation of RAS Inhibitors Does Not Increase eGFR in CKD
WEDNESDAY, Nov. 9, 2022 (HealthDay News) — For patients with advanced and progressive chronic kidney disease, discontinuation of treatment with renin-angiotensin system (RAS) inhibitors is not associated with a difference in the long-term rate of dec…
Learn MoreLinks Explored Between Antidiabetic Meds, Multiple Sclerosis Risk
WEDNESDAY, Nov. 9, 2022 (HealthDay News) — For patients with type 2 diabetes (T2D), exposure to antihyperglycemic medications (A-HgMs) is associated with a decreased risk for developing multiple sclerosis (MS) in those who are younger than 45 years a…
Learn MoreLinks Explored Between Antidiabetic Meds, Multiple Sclerosis Risk
WEDNESDAY, Nov. 9, 2022 (HealthDay News) — For patients with type 2 diabetes (T2D), exposure to antihyperglycemic medications (A-HgMs) is associated with a decreased risk for developing multiple sclerosis (MS) in those who are younger than 45 years a…
Learn MorePaxlovid reduce el riesgo de COVID prolongada
LUNES, 7 de noviembre de 2022 (HealthDay News) — La pastilla antiviral Paxlovid no solo reduce las hospitalizaciones y las muertes tras contraer la COVID-19: una nueva investigación muestra que también reduce las probabilidades de COVID prolongada en…
Learn MoreAHA: Baxdrostat Studied in Treatment-Resistant Hypertension
TUESDAY, Nov. 8, 2022 (HealthDay News) — Patients with treatment-resistant hypertension who receive baxdrostat versus placebo have dose-dependent reductions in systolic blood pressure at 12 weeks, according to a study published online Nov. 7 in the N…
Learn MoreAHA: Lowering TGs With Pemafibrate Does Not Cut CV Risk in T2DM
TUESDAY, Nov. 8, 2022 (HealthDay News) — For patients with type 2 diabetes, hypertriglyceridemia, and low high-density lipoprotein cholesterol levels, the incidence of cardiovascular events is not lower with pemafibrate versus placebo, according to a…
Learn MoreLipid-Lowering, Antidiabetic Drugs Tied to Prevalence of AMD
TUESDAY, Nov. 8, 2022 (HealthDay News) — Lipid-lowering drugs (LLDs) and antidiabetic drugs are associated with lower prevalence of any age-related macular degeneration (AMD), according to a meta-analysis published online Nov. 7 in the British Journa…
Learn MoreNew Drug Helps Tame Uncontrolled High Blood Pressure
TUESDAY, Nov. 8, 2022 (HealthDay News) – Some patients with high blood pressure can’t get it under control with standard medications, but a new study shows an experimental drug is up to the task of treating these tough-to-treat cases.Why do some folks…
Learn MoreStudy Compares 2 Common Diuretics Used in Heart Failure
TUESDAY, Nov. 8, 2022 (HealthDay News) — Patients with heart failure are often prescribed a diuretic or “water pill” to prevent fluid buildup. A new study has found that two often-prescribed medications work equally well at reducing deaths. “Given th…
Learn MoreTelmisartan Linked to Reduced Risk for Alzheimer Disease in Black Patients
MONDAY, Nov. 7, 2022 (HealthDay News) — In African American patients, telmisartan is associated with a reduced risk for Alzheimer disease (AD), according to a study published online Nov. 4 in Alzheimer’s & Dementia.Pengyue Zhang, Ph.D., from Indiana …
Learn More